The authors investigated neuropsychiatric symptoms in mild cognitive impairment (MCI) from baseline data of the Investigation in the Delay to Diagnosis of AD with Exelon (InDDEx) study (n = 1,010). Neuropsychiatric symptoms were reported in 59% of subjects (Neuropsychiatric Inventory [NPI]). NPI+ subjects had significantly greater impairment on global, cognitive, and functional scores than NPI- subjects. The presence of neuropsychiatric symptoms appears to be a marker of MCI severity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1212/01.wnl.0000118301.92105.ee | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!